Literature DB >> 16988450

Surface-modified biodegradable microspheres for DNA vaccine delivery.

Mark E Keegan1, W Mark Saltzman.   

Abstract

Encapsulating DNA within degradable delivery vehicles such as micro- or nanospheres provides an effective way to protect the DNA from the surrounding environment prior to delivery. The ability to target these vehicles directly to the cell type of interest provides a way to enhance the overall efficiency of DNA delivery. One means of highly specific cell targeting is through the addition to the vehicle surface of ligands that bind specifically to receptors on the surface of the targeted cell type. Covalent conjugation of ligands to the surface of degradable delivery vehicles can be difficult, as the most commonly used vehicle formulations use materials selected for their general chemical inertness. This chapter describes methods for overcoming this, enabling encapsulation of DNA within degradable microspheres made of a commonly used biomaterial and then covalently conjugating ligands to the surface of these microspheres.

Mesh:

Substances:

Year:  2006        PMID: 16988450     DOI: 10.1385/1-59745-168-1:107

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  7 in total

Review 1.  Medical biofilms.

Authors:  James D Bryers
Journal:  Biotechnol Bioeng       Date:  2008-05-01       Impact factor: 4.530

2.  Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.

Authors:  Christopher J Cheng; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

3.  The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.

Authors:  Malgorzata S Cartiera; Katherine M Johnson; Vanathy Rajendran; Michael J Caplan; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-02-20       Impact factor: 12.479

4.  Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.

Authors:  Kyoungmin Park; Ying Chen; Yang Hu; Aaron S Mayo; Uday B Kompella; Richard Longeras; Jian-xing Ma
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

5.  Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.

Authors:  Julia Kim; Vandana Gambhir; Attiya Alatery; Sameh Basta
Journal:  J Biomed Biotechnol       Date:  2010-05-23

6.  A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Authors:  Brett Phillips; Karen Nylander; Jo Harnaha; Jennifer Machen; Robert Lakomy; Alexis Styche; Kimberly Gillis; Larry Brown; Debra Lafreniere; Michael Gallo; Janet Knox; Kenneth Hogeland; Massimo Trucco; Nick Giannoukakis
Journal:  Diabetes       Date:  2008-03-03       Impact factor: 9.461

Review 7.  Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Authors:  Brett Phillips; Massimo Trucco; Nick Giannoukakis
Journal:  Clin Dev Immunol       Date:  2011-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.